{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:43:06Z","timestamp":1794494586012,"version":"4.9.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"R2","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08HD086250"],"award-info":[{"award-number":["K08HD086250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Icelandic Research Fund","award":["195835-051"],"award-info":[{"award-number":["195835-051"]}]},{"name":"Louma G. Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The epigenetic machinery in conjunction with the transcriptional machinery is responsible for maintaining genome-wide chromatin states and dynamically regulating gene expression. Mendelian disorders of the epigenetic machinery (MDEMs) are genetic disorders resulting from mutations in components of the epigenetic apparatus. Though individually rare, MDEMs have emerged as a collectively common etiology for intellectual disability (ID) and growth disruption. Studies in model organisms and humans have demonstrated dosage sensitivity of this gene group with haploinsufficiency as a predominant disease mechanism. The epigenetic machinery consists of three enzymatic components (writers, erasers and chromatin remodelers) as well as one non-enzymatic group (readers). A tally of the entire census of such factors revealed that although multiple enzymatic activities never coexist within a single component, individual enzymatic activities often coexist with a reader domain. This group of disorders disrupts both the chromatin and transcription states of target genes downstream of the given component but also DNA methylation on a global scale. Elucidation of these global epigenetic changes may inform our understanding of disease pathogenesis and have diagnostic utility. Moreover, many therapies targeting epigenetic marks already exist, and some have proven successful in treating cancer. This, along with the recent observation that neurological dysfunction in these disorders may in fact be treatable in postnatal life, suggests that the scientific community should prioritize this group as a potentially treatable cause of ID. Here we summarize the recent expansion and major characteristics of MDEMs, as well as the unique therapeutic prospects for this group of disorders.<\/jats:p>","DOI":"10.1093\/hmg\/ddz174","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T15:27:57Z","timestamp":1570548477000},"page":"R254-R264","source":"Crossref","is-referenced-by-count":150,"title":["Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects"],"prefix":"10.1093","volume":"28","author":[{"given":"Jill A","family":"Fahrner","sequence":"first","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, 21205"},{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans T","family":"Bjornsson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"},{"name":"Landspitali University Hospital, Reykjavik 101, Iceland"},{"name":"Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland"},{"name":"McKusick-Nathans Institute of Genetic Medicine, 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"2020012623564443100_ref1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev-genom-090613-094245","article-title":"Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states","volume":"15","author":"Fahrner","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2020012623564443100_ref2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1101\/gr.190629.115","article-title":"The Mendelian disorders of the epigenetic machinery","volume":"25","author":"Bjornsson","year":"2015","journal-title":"Genome Res."},{"key":"2020012623564443100_ref3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1101\/gr.239442.118","article-title":"Coexpression patterns define epigenetic regulators associated with neurological dysfunction","volume":"29","author":"Boukas","year":"2019","journal-title":"Genome Res."},{"key":"2020012623564443100_ref4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006105","article-title":"Epigenome-wide association studies and the interpretation of disease-omics","volume":"12","author":"Birney","year":"2016","journal-title":"PLoS Genet."},{"key":"2020012623564443100_ref5","doi-asserted-by":"crossref","first-page":"256ra135","DOI":"10.1126\/scitranslmed.3009278","article-title":"Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome","volume":"6","author":"Bjornsson","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2020012623564443100_ref6","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1523\/JNEUROSCI.1840-17.2017","article-title":"Epigenetic etiology of intellectual disability","volume":"37","author":"Iwase","year":"2017","journal-title":"J. Neurosci."},{"key":"2020012623564443100_ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajhg.2017.11.013","article-title":"Histone lysine methylases and demethylases in the landscape of human developmental disorders","volume":"102","author":"Faundes","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"2020012623564443100_ref8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajhg.2017.03.010","article-title":"Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability","volume":"100","author":"Tatton-Brown","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"2020012623564443100_ref9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129380","article-title":"Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice","author":"Fahrner","year":"2019"},{"key":"2020012623564443100_ref10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41588-018-0274-x","article-title":"Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions","volume":"51","author":"Heyn","year":"2019","journal-title":"Nat. Genet."},{"key":"2020012623564443100_ref11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129375","article-title":"Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome","author":"Carosso","year":"2019"},{"key":"2020012623564443100_ref12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","article-title":"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy","volume":"21","author":"Winkelmann","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"2020012623564443100_ref13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrg3413","article-title":"From neural development to cognition: unexpected roles for chromatin","volume":"14","author":"Ronan","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"2020012623564443100_ref14","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.celrep.2015.02.011","article-title":"Loss-of-function mutation in APC2 causes Sotos syndrome features","volume":"10","author":"Almuriekhi","year":"2015","journal-title":"Cell Rep."},{"key":"2020012623564443100_ref15","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0906831106","article-title":"Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma","volume":"106","author":"Berdasco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"2020012623564443100_ref16","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1172\/JCI80102","article-title":"RAP1-mediated MEK\/ERK pathway defects in Kabuki syndrome","volume":"125","author":"B\u00f6gershausen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2020012623564443100_ref17","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1242\/dev.047894","article-title":"The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear","volume":"137","author":"Hurd","year":"2010","journal-title":"Development"},{"key":"2020012623564443100_ref18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng863","article-title":"Haploinsufficiency of NSD1 causes Sotos syndrome","volume":"30","author":"Kurotaki","year":"2002","journal-title":"Nat. Genet."},{"key":"2020012623564443100_ref19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng.646","article-title":"Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"key":"2020012623564443100_ref20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajhg.2011.11.021","article-title":"Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome","volume":"90","author":"Lederer","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"2020012623564443100_ref21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41431-017-0023-0","article-title":"Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities","volume":"25","author":"Sobreira","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"2020012623564443100_ref22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-016-0254-x","article-title":"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy","volume":"8","author":"Kernohan","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"2020012623564443100_ref23","doi-asserted-by":"crossref","DOI":"10.1038\/srep38803","article-title":"The defining DNA methylation signature of Floating\u2013Harbor syndrome","volume":"6","author":"Hood","year":"2016","journal-title":"Sci. Rep."},{"key":"2020012623564443100_ref24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13072-017-0118-4","article-title":"Identification of epigenetic signature associated with alpha thalassemia\/mental retardation X-linked syndrome","volume":"10","author":"Schenkel","year":"2017","journal-title":"Epigenetics Chromatin"},{"key":"2020012623564443100_ref25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10207","article-title":"NSD1 mutations generate a genome-wide DNA methylation signature","volume":"6","author":"Choufani","year":"2015","journal-title":"Nat. Commun."},{"key":"2020012623564443100_ref26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ajhg.2017.04.004","article-title":"CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions","volume":"100","author":"Butcher","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"2020012623564443100_ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13148-018-0453-8","article-title":"Peripheral blood epi-signature of Claes\u2013Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C","volume":"10","author":"Schenkel","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"2020012623564443100_ref28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ajhg.2019.03.008","article-title":"Diagnostic utility of genome-wide DNA methylation testing in genetically unsolved individuals with suspected hereditary conditions","volume":"104","author":"Aref-Eshghi","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"2020012623564443100_ref29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.sbi.2007.08.008","article-title":"Enzymes as a special class of therapeutic target: clinical drugs and modes of action","volume":"17","author":"Robertson","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2020012623564443100_ref30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12272-014-0455-9","article-title":"Targeting components of epigenome by small molecules","volume":"37","author":"You","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"2020012623564443100_ref31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"2020012623564443100_ref32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/- mice: a model for the cognitive deficit in Rubinstein\u2013Taybi syndrome and its amelioration","volume":"42","author":"Alarc\u00f3n","year":"2004","journal-title":"Neuron"},{"key":"2020012623564443100_ref33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"key":"2020012623564443100_ref34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1611431114","article-title":"A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome","volume":"114","author":"Benjamin","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2020012623564443100_ref35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.14348\/molcells.2015.0103","article-title":"Measuring and reducing off-target activities of programmable nucleases including CRISPR-Cas9","volume":"38","author":"Koo","year":"2015","journal-title":"Mol. Cells"},{"key":"2020012623564443100_ref36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"2020012623564443100_ref37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aag2445","article-title":"Systematic mapping of functional enhancer-promoter connections with CRISPR interference","volume":"354","author":"Fulco","year":"2016","journal-title":"Science"},{"key":"2020012623564443100_ref38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/epi.14.23","article-title":"EZH2 as a potential target in cancer therapy","volume":"6","author":"McCabe","year":"2014","journal-title":"Epigenomics"},{"key":"2020012623564443100_ref39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chembiol.2014.11.021","article-title":"Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain","volume":"22","author":"Ren","year":"2015","journal-title":"Chem. Biol."},{"key":"2020012623564443100_ref40","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2174\/1568026619666181120150122","article-title":"DNA methyltransferase inhibitors and their therapeutic potential","volume":"18","author":"Zhou","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"2020012623564443100_ref41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/15592294.2016.1265710","article-title":"Bromodomain inhibitors and cancer therapy: from structures to applications","volume":"12","author":"P\u00e9rez-Salvia","year":"2017","journal-title":"Epigenetics"},{"key":"2020012623564443100_ref42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2019.05.078","article-title":"Histone acetyltransferase inhibitors: an overview in synthesis, structure-activity relationship and molecular mechanism","volume":"178","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"2020012623564443100_ref43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026484","article-title":"Histone lysine demethylase inhibitors","volume":"7","author":"Jambhekar","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2020012623564443100_ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnmol.2018.00252","article-title":"Mutational landscapes and phenotypic Spectrum of SWI\/SNF-related intellectual disability disorders","volume":"11","author":"B\u00f6gershausen","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"2020012623564443100_ref45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature10423","article-title":"Deep sequencing reveals 50 novel genes for recessive cognitive disorders","volume":"478","author":"Najmabadi","year":"2011","journal-title":"Nature"},{"key":"2020012623564443100_ref46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajhg.2013.05.007","article-title":"De novo mutations in the genome organizer CTCF cause intellectual disability","volume":"93","author":"Gregor","year":"2013","journal-title":"Am. J. Hum. Genet."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddz174\/30116597\/ddz174.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/R2\/R254\/31959449\/ddz174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/R2\/R254\/31959449\/ddz174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,26]],"date-time":"2020-01-26T23:57:05Z","timestamp":1580083025000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/R2\/R254\/5583234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":46,"journal-issue":{"issue":"R2","published-online":{"date-parts":[[2019,10,8]]},"published-print":{"date-parts":[[2019,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddz174","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,15]]},"published":{"date-parts":[[2019,10,8]]}}}